跳至主要内容
临床试验/DRKS00032898
DRKS00032898已完成不适用

Safety of anthelmintic medication during pregnancy: An evaluation of pregnancy outcomes based on the Embryotox cohort

Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie Charité – Universitätsmedizin Berlin0 个研究点目标入组 323 人开始时间: 2024年3月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
323

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
Female

入选标准

  • Contact with Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Berlin for consultation in pregnancy during the study period (01.01.2000 - 28.02.2023) and exposure to study medication during pregnancy.
  • At first contact with Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, the pregnancy outcome is unknown and there are no reported pathological findings. Information on pregnancy outcome is completed; quality of information/data must meet internal standards.

排除标准

  • Non-plausible or missing relevant data.

研究者

发起方
Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie Charité – Universitätsmedizin Berlin

相似试验

Safety of anthelmintic medication during pregnancy:... | 临床试验